Cascade Technologies Corp  

(Public, OTCMKTS:CSDT)   Watch this stock  
Find more results for EUGENE FARKAS
0.00770
-0.00020 (-2.53%)
Mar 26 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.01 - 0.01
52 week 0.00 - 0.02
Open 0.01
Vol / Avg. 2,000.00/41,031.00
Mkt cap 1.65M
P/E     -
Div/yield     -
EPS -0.01
Shares 214.79M
Beta -4.89
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -292.24% -585.24%
Return on average equity - -
Employees 3 -
CDP Score - -

Address

250 N Robertson Blvd Ste 427
BEVERLY HILLS, CA 90211-1777
United States - Map
+1-310-8581670 (Phone)

Description

Cascade Technologies Corp. is engaged in developing medical imaging products. The Company operates through its wholly owned subsidiary, Spectral Molecular Imaging, Inc. (SMI). Cascade Technologies Corp. develops three products, which include the SkinSpect device, the EndoSpect device, and the OxySpect device. The SkinSpect device addresses the need for early, reliable, non-invasive diagnosis of cancer and screening for skin cancer. The EndoSpect device is a hyperspectral imaging endoscope used to assess tissue status during minimally invasive surgery (gastro-intestinal, pulmonary or other endoscopy). The EndoSpect device is a hyperspectral imaging endoscope used to assess tissue status during minimally invasive surgery (gastro-intestinal, pulmonary or other endoscopy). The OxySpect device maps tissue oxygenation by spectral imaging in a range of body locations.

Officers and directors

Daniel L. Farkas Ph.D. Chairman of the Board, Acting Chief Executive Officer
Age: 60
Eugene Scher Chief Financial Officer, Chief Operating Officer, Director
Age: 63